Swantje
Swantje Behnken, Jena DE
Patent application number | Description | Published |
---|---|---|
20120270940 | Closthioamides - This invention relates to the field of biologically active compounds and specifically to closthioamides, pharmaceutical compositions comprising these compounds, and their use as antibiotic, antifungal, and/or cytotoxic agent. | 10-25-2012 |
Swantje Duncker, Lausanne CH
Patent application number | Description | Published |
---|---|---|
20120183506 | PREVENTION AND TREATMENT OF ALLERGIC DIARRHOEA - This invention relates to | 07-19-2012 |
20140170126 | PROBIOTIC FOR ADMINISTRATION TO HEALTHY YOUNG MAMMALS DURING THE WEANING PERIOD FOR IMPROVING TOLERANCE TO NEWLY INTRODUCED FOOD STUFFS - The current invention is based upon administration of a probiotic, | 06-19-2014 |
Swantje Mindorf, Burg DE
Patent application number | Description | Published |
---|---|---|
20080293625 | Diagnosis of Inflammatory Bowel Diseases, More Particularly Ulcerative Colitis - The present invention concerns goblet cell antigen, a method for detecting antibodies directed against goblet cell antigen, a method based thereon for diagnosis of inflammatory bowel diseases and a kit for diagnosis of inflammatory bowel diseases, as well as monoclonal antibodies directed against goblet cell antigen. | 11-27-2008 |
Swantje Thiering, Gillingham GB
Patent application number | Description | Published |
---|---|---|
20100286392 | PROCESS FOR THE MANUFACTURING OF THE COMPOUND 2-HYDROXY-3-[5-(MORPHOLIN-4-YLMETHYL)PYRIDIN-2-YL]1H-INDOLE-5-CARBONITRIL- E 701 - The present invention relates to a new process for the manufacture of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile as a free base and pharmaceutically acceptable salts thereof, particularly the 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile citrate, and to new intermediates prepared in said process suitable for large scale manufacturing of said compound. | 11-11-2010 |